Publication | Closed Access

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema11The authors have no proprietary interest in this study. 22Dr Audren, co–first author, contributed equally to the work.

Diabetic RetinopathyOcular DiseaseVitreous BodyOphthalmologyIntravitreal Triamcinolone AcetonideDiabetesPharmacologyCo–first AuthorGlaucomaOcular PathologyProprietary InterestMedicine